The aim of hip revison surgery is to restore biomechanical parameters: rotation centre, muscle arm lever and leg length; homologous bone grafting is often necessary. It is possible to bioenhance grafts, resulting in better osteointegration speed and quality. We propose the use of our platelet gel protocol. Care was given to assess the cost-benefit rate of the method. We performed densitometric analysis of homologous bioenhanced grafts vs homologous grafts, with a specific acetabular bone loss indication, randomising two groups of patients (rct study). The “intention to treat” was to decide the benefit of the method in order to extend use to all patients. Densitometric analysis was implemented with radiographic analysis using a modified Cook’s scale. We used clinical scores, too. The clinical and plain radiographic results did not differ significantly between the two groups or with our historical group (7 years/23 implants, already published). The synthesis of all instruments used indicates that the use of bioenhanced bone is promising for enhanced osteointegration; however, the study group must be extended and observed for a longer time to achieve appropriate study power.